nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation
Clinical trial NCT01824394 · TERMINATED
Trial details
- NCT number
- NCT01824394
- Sponsor
- Biosense Webster, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2017-11-26
- Enrollment
- 481
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.